NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,526,000 | +111.7% | 20,545 | +107.5% | 0.05% | +200.0% |
| Q4 2016 | $721,000 | -80.8% | 9,900 | -79.2% | 0.02% | -77.6% |
| Q3 2016 | $3,758,000 | -29.8% | 47,600 | -26.7% | 0.08% | -16.5% |
| Q2 2016 | $5,355,000 | +111.8% | 64,900 | +86.0% | 0.09% | +106.8% |
| Q1 2016 | $2,528,000 | +238.4% | 34,895 | +302.1% | 0.04% | +450.0% |
| Q4 2015 | $747,000 | -75.9% | 8,679 | -74.3% | 0.01% | -73.3% |
| Q3 2015 | $3,099,000 | +313.2% | 33,718 | +343.7% | 0.03% | +328.6% |
| Q1 2015 | $750,000 | -79.1% | 7,600 | -80.4% | 0.01% | -68.2% |
| Q4 2014 | $3,597,000 | +9.4% | 38,817 | +11.2% | 0.02% | +37.5% |
| Q3 2014 | $3,287,000 | -61.5% | 34,921 | -63.0% | 0.02% | -61.0% |
| Q2 2014 | $8,540,000 | -32.6% | 94,335 | -36.7% | 0.04% | -42.3% |
| Q1 2014 | $12,678,000 | +11.3% | 149,123 | +5.3% | 0.07% | +16.4% |
| Q4 2013 | $11,386,000 | +16.6% | 141,647 | +11.2% | 0.06% | +1.7% |
| Q3 2013 | $9,769,000 | +64.0% | 127,347 | +51.2% | 0.06% | +62.2% |
| Q2 2013 | $5,957,000 | – | 84,247 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |